Related Experiment Video
Updated: Aug 26, 2026
Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model
Published on: April 6, 2021
[Pseudomonas aeruginosa colonization in Turin CF center. Microbiological and therapeutic observations]
1Divisione di Pneumologia, Ospedale Infantile Regina Margherita, Torino.
Abstract:
We reviewed 4,277 sputum cultures performed in our FC patients during antipseudomonas courses of antibiotic therapy. The median age of colonization is 8.6 years, and the chronically infected subjects are 33.65% of all our patients. The most efficient antibiotics were imipenem, aztreonam, ceftazidime and amikacin. Ceftazidime gave the best results in terms of antibiotic resistance.
Insights
This study found that ceftazidime was the most effective antibiotic for treating Pseudomonas aeruginosa infections in cystic fibrosis (CF) patients, showing the best results for antibiotic resistance. Other effective antibiotics included imipenem, aztreonam, and amikacin.
Area of Science:
- Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Pseudomonas aeruginosa is a significant pathogen in cystic fibrosis (CF) patients.
- Chronic infection with P. aeruginosa impacts patient health and treatment outcomes.
- Antibiotic resistance is a growing concern in managing CF pulmonary infections.
Purpose of the Study:
- To evaluate the efficacy of various antipseudomonas antibiotics in CF patients.
- To identify antibiotics with the best outcomes regarding resistance.
- To characterize the prevalence and age of P. aeruginosa colonization in CF patients.
Main Methods:
- Retrospective review of 4,277 sputum cultures from CF patients undergoing antipseudomonas antibiotic therapy.
- Analysis of antibiotic susceptibility patterns.
- Determination of colonization age and prevalence in the patient cohort.
Main Results:
- The median age of P. aeruginosa colonization was 8.6 years.
- Chronically infected patients constituted 33.65% of the study population.
- Imipenem, aztreonam, ceftazidime, and amikacin demonstrated high efficacy.
- Ceftazidime exhibited the most favorable results concerning antibiotic resistance.
Conclusions:
- Ceftazidime is a highly effective antibiotic for P. aeruginosa infections in CF patients, particularly in managing antibiotic resistance.
- Early colonization and chronic infection are prevalent in this CF cohort.
- A range of antipseudomonas antibiotics are effective, but resistance patterns necessitate careful selection.
